The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies.

Introduction: The identification of upper gastrointestinal (UGI) bleeding and perforated ulcers in claims data typically relies on inpatient diagnoses. The use of hemoglobin laboratory results might increase the detection of UGI events that do not lead to hospitalization.Objectives: Our objective wa...

Full description

Bibliographic Details
Published in:Drug Safety Vol. 40; no. 1; pp. 91 - 101
Main Authors: Patorno, Elisabetta, Gagne, Joshua, Lu, Christine, Haynes, Kevin, Sterrett, Andrew, Roy, Jason, Wang, Xingmei, Raebel, Marsha, Gagne, Joshua J, Lu, Christine Y, Sterrett, Andrew T, Raebel, Marsha A
Format: research tables/charts Journal Article
Published: Springer Nature Jan2017
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120531049&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 120531049
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01145916
        C5E
      jtl: Drug Safety
      issn: 01145916
      maglogo: N
    pubinfo:
      dt: Jan2017
      vid: 40
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        120531049
        120531049
        144012509
        NLM27848201
        120531049
        10.1007/s40264-016-0472-3
        NLM27848201
        120531049
      ppf: 91
      ppct: 10
      formats:
      tig:
        atl: The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies.
      aug:
        au:
          Patorno, Elisabetta
          Gagne, Joshua
          Lu, Christine
          Haynes, Kevin
          Sterrett, Andrew
          Roy, Jason
          Wang, Xingmei
          Raebel, Marsha
          Gagne, Joshua J
          Lu, Christine Y
          Sterrett, Andrew T
          Raebel, Marsha A
        affil: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine , Brigham and Women's Hospital and Harvard Medical School , 1620 Tremont Street (Suite 3030) Boston 02120 USA
      sug:
        subj:
          Antiinflammatory Agents, Non-Steroidal Adverse Effects
          Hemoglobins Analysis
          Peptic Ulcer Chemically Induced
          Gastrointestinal Hemorrhage Chemically Induced
          Gastrointestinal Hemorrhage Diagnosis
          Adult
          Adverse Drug Event
          Male
          Sentinel Event
          Aged
          Inpatients
          Resource Databases
          Coding
          Prospective Studies
          Middle Age
          Time Factors
          Female
          Human
          Adverse Drug Event Epidemiology
          Peptic Ulcer Diagnosis
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Introduction: The identification of upper gastrointestinal (UGI) bleeding and perforated ulcers in claims data typically relies on inpatient diagnoses. The use of hemoglobin laboratory results might increase the detection of UGI events that do not lead to hospitalization.Objectives: Our objective was to evaluate whether hemoglobin results increase UGI outcome identification in electronic databases, using non-steroidal anti-inflammatory drugs (NSAIDs) as a test case.Methods: From three data partner sites within the Mini-Sentinel Distributed Database, we identified NSAID initiators aged ≥18 years between 2008 and 2013. Numbers of events and risks within 30 days after NSAID initiation were calculated for four mutually exclusive outcomes: (1) inpatient UGI diagnosis of bleeding or gastric ulcer (standard claims-based definition without laboratory results); (2) non-inpatient UGI diagnosis AND ≥3 g/dl hemoglobin decrease; (3) ≥3 g/dl hemoglobin decrease without UGI diagnosis in any clinical setting; (4) non-inpatient UGI diagnosis, without ≥3 g/dl hemoglobin decrease.Results: We identified 2,289,772 NSAID initiators across three sites. Overall, 45.3% had one or more hemoglobin result available within 365 days before or 30 days after NSAID initiation; only 6.8% had results before and after. Of 7637 potential outcomes identified, outcome 1 accounted for 21.7%, outcome 2 for 0.8%, outcome 3 for 34.3%, and outcome 4 for 43.3%. Potential cases identified by outcome 3 were largely not suggestive of UGI events. Outcomes 1, 2, and 4 had similar distributions of specific UGI diagnoses.Conclusions: Using available hemoglobin result values combined with non-inpatient UGI diagnoses identified few additional UGI cases. Non-inpatient UGI diagnostic codes may increase outcome detection but would require validation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N